Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl. (April 2017) - Luft, T.; Radujkovic, A.; Nowak, D.; Fricke, H.; Kunz, C.; Hofmann, W.K.; Nolte, F.; Dreger, P.; Boch, T.